Here, we investigated whether pretreatment with anti-VEGF(R) and/or -PDGFR drugs enhances tumor penetration and increases efficacy of intraperitoneal Oxaliplatin perfusion in a mouse peritoneal carcinomatosis model. Here, PDGFRB is linked to neoplasm.